Yet, despite this widespread use for therapeutic and medicinal reasons, the picture for safe and effective CBD still isn’t clear.


Providing legitimacy from the World Health Organization
One of the reasons why there is still so much confusion is that CBD remains classified as a Schedule I controlled substance. Due to its origins as a cannabis component, CBD is the non-psychoactive chemical in cannabis, although it doesn’t have the “high” feeling that many people associate with it.

The World Health Organization (WHO) report has found no adverse health outcomes with no potential for abuse. In addition, the WHO team determined that CBD has "been demonstrated as an effective treatment for epilepsy" in adults, children, and even animals and that there's "preliminary evidence" that CBD could be useful in treating Alzheimer's disease, insomnia, psychosis, and Parkinson's disease.


CBD has positive anti-inflammatory effects
As noted in Harvard Health, one animal study from the European Journal of Pain suggests CBD could help lower pain and inflammation due to arthritis when applied to your skin. CBD research may still be in its infancy, but advancements in various testing may help prove that it is a safe option for managing anxiety and chronic pain.


Not all CBD companies are created equally
According to Harvard Health, all 50 states have laws legalizing CBD with varying degrees of restriction. Several unsanctioned states promote products through companies that don’t use the same methods of cannabis extraction. It’s important to ensure it’s coming from a reputable source that uses the highest operational standards, rigorous third-party testing, and doesn’t use unknown elements.


About Renewsha

Renewsha offers scientifically-backed, premium CBD tablets through patented technology, leading to better results. Their mission is to help people flourish and thrive by prescribing nature. For more information on Renewsha’s Premium CBD, visit renewsha.com.